Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
12 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-02-09 | 2023-07-06 | 184201 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-06-19 | 2023-06-21 | 195512 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2023-10-26 | 2023-11-23 | 208254 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-10-26 | 2023-11-03 | 208257 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218129 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2024-06-27 | 2024-07-26 | 231427 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2024-07-04 | 2024-07-26 | 232220 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2024-10-11 | 2025-09-02 | 240053 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2024-10-22 | 2025-09-02 | 240877 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2024-10-22 | 2025-09-02 | 240880 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 0.5MG 50MCG | OINTMENT | Resolved | 2021-04-08 | 2021-07-15 | 137212 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2022-02-10 | 2022-04-01 | 154717 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2022-09-22 | 2022-12-02 | 169961 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2023-06-26 | 2023-07-06 | 196403 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2025-02-28 | 2025-06-19 | 251445 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 0.5MG 50MCG | OINTMENT | Resolved | 2025-08-29 | 2025-09-11 | 266193 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 0.5MG 50MCG | OINTMENT | Actual shortage | 2025-10-10 | 2025-12-04 | 269246 |
| TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Actual shortage | 2025-12-04 | 2025-12-04 | 273311 |
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-04-03 | 2017-05-10 | 5174 |
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-11-16 | 2018-03-13 | 29450 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |